However, while this current study confirms a reduction in small-medium HDL concentrations, we did not see changes in cholesterol ester, triglyceride, or anti-ApoA1 antibody levels, most likely because most studies have been performed on adult SLE cohorts. This evidence concerns the gene APOA1 and systemic lupus erythematosus.